Spesolimab in Pyoderma Gangrenosum
Condition(s):Pyoderma GangrenosumLast Updated:January 30, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Pyoderma GangrenosumLast Updated:January 30, 2024Recruiting
Condition(s):Pyoderma GangrenosumLast Updated:November 15, 2021Unknown status
Condition(s):Pyoderma GangrenosumLast Updated:August 20, 2018Unknown status
Condition(s):Pyoderma GangrenosumLast Updated:March 9, 2021Completed
Condition(s):Pyoderma GangrenosumLast Updated:January 17, 2023Recruiting
Condition(s):Pyoderma GangrenosumLast Updated:January 25, 2024Not yet recruiting
Condition(s):Pyoderma GangrenosumLast Updated:February 3, 2016Completed
Condition(s):Pyoderma GangrenosumLast Updated:January 28, 2021Completed
Condition(s):Pyoderma GangrenosumLast Updated:April 27, 2016Terminated
Condition(s):Pyoderma GangrenosumLast Updated:April 27, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.